Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 306-005-7 | CAS number: 95465-90-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP, non-guideline study, published in peer reviewed literature, minor restrictions in design and/or reporting but otherwise adequate for assessment
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Uptake, distribution, and formation of hemoglobin and DNA adducts after inhalation of C2-C8 1-alkenes (olefins) in the rat.
- Author:
- Eide I, Hagemann R, Zahlsen K, Tareke E, Törnqvist M, Kumar R, Vodicka P and Hemminki K.
- Year:
- 1 995
- Bibliographic source:
- Carcinogenesis 16:1603-1609
Materials and methods
- Objective of study:
- absorption
- distribution
- excretion
- other: haemoglobin and DNA adduct formation
- Principles of method if other than guideline:
- A homologous series of C2-C8 1-alkenes (olefins) were investigated in inhalation experiments with rats. The structure activity approach gave information about uptake, distribution and formation of haemoglobin and DNA adducts in relation to the number of carbon atoms in the olefins.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- 1-butene
- IUPAC Name:
- 1-butene
- Details on test material:
- 1-butene (>99%) was obtained from HydroGas AS, Norway
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Mǿllgaard A/S, Ll. Skensved, Denmark
- Age at study initiation: no data
- Weight at study initiation: 180-225 g.
- Housing: There were eight animals in each cage and a maximum of four cages in each inhalation chamber.
- Diet: ad libitum except during exposure.
- Water: ad libitum except during exposure.
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 21±1°C
- Humidity: 65± 5%
- Air changes (per hr): 10 per hr
- Photoperiod: 10 hrs dark / 14 hrs light
IN-LIFE DATES: no data
Administration / exposure
- Route of administration:
- inhalation
- Vehicle:
- other: air
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: whole body
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: conically shaped 0.7 m3 steel chambers with glass front doors and walls
- System of generating test atmosphere: The aimed concentrations of C2 to C4 gases in the exposure chambers were generated by introducing a controlled stream of pure gas delivered by a two-stage precision pressure regulator.
TEST ATMOSPHERE
- Monitored hourly by gas chromatography - Duration and frequency of treatment / exposure:
- 12 h/day for 3 consecutive days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
300 ppm
- No. of animals per sex per dose / concentration:
- A minimum of 8 males
- Control animals:
- yes, concurrent no treatment
- Positive control reference chemical:
- none
- Details on study design:
- see below
- Details on dosing and sampling:
- see below
- Statistics:
- none
Results and discussion
- Preliminary studies:
- not applicable
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- not determined
- Details on distribution in tissues:
- see below
Transfer into organs
- Transfer type:
- other:
- Details on excretion:
- not determined
Toxicokinetic parameters
- Toxicokinetic parameters:
- other:
Metabolite characterisation studies
- Metabolites identified:
- not measured
- Details on metabolites:
- Concentrations of 1-alkenes in blood and organs reached a steady-state level after the first 12 h exposure, and the concentrations 12 h after the last exposure were generally low, except in fat tissue. Concentrations of 1-alkenes in blood and the different tissues increased with increasing number of carbon atoms. Levels of haemoglobin and DNA adducts decreased with increasing number of carbon atoms with the most pronounced decrease from C2 to C3. The decrease through the whole homologous series from C2 to C8 was most pronounced for haemoglobin adducts followed by the DNA adducts in the lymphocytes. Detectable levels of haemoglobin and DNA adducts were produced by all 1-alkenes, although the levels of haemoglobin adducts after C4-C8 exposure were low.
Any other information on results incl. tables
Concentrations of individual 1-alkenes after the third 12 h exposure to 300 ppm and concentrations in fat 12 h after the final exposure
|
blood |
liver |
lung |
brain |
kidneys |
fat |
Fat 12 h elim |
Ethane |
0.3±0.1 |
0.4±0.1 |
2.3±0.5 |
0.7±0.1 |
0.7±0.1 |
7±1 |
nd |
Propene |
1.1 ±0.2 |
0.3±0.2 |
2.9± 1.3 |
1.7±0.3 |
1.8±0.2 |
36±4 |
nd |
1-butene |
1.9±0.1 |
0.8±0.3 |
4.9± 1.1 |
3.0±0.3 |
5.7±1.4 |
70±8 |
0.3±0.1 |
1-pentene |
8.6±1.4 |
51.6±12.9 |
31.4±10.6 |
41.0±4.9 |
105.7±13.7 |
368±79 |
19±9 |
1-hexene |
18.2±1.1 |
66.8±1.2 |
59.7± 17.7 |
59.7±4.6 |
188.0±21.7 |
1031±54 |
77±49 |
1-heptene |
37.0±1.8 |
138.3±9.7 |
85.6±8.2 |
109.3±5.5 |
269.3±21.8 |
2598±253 |
293±167 |
1-octene |
60.1±2.2 |
443.7±26.9 |
202.4±29.5 |
270.0±9.5 |
385.1±32.6 |
4621±468 |
943±480 |
N=4, mean +/- SD
All concentrations are in µmol/kg; nd = not detectable
Adjustment factors for exhalatory loss of C2 -C4 1 -alkenes ranged from 1.00 to 1.10.
Mean levels of N-(2-hydroxyalkyl)valine in haemoglobin (pmol/g) and 7-alkylguanine adducts in lymphocytes and liver (adducts/107normal nucleotides) formed after exposing rats to the 1-alkenes.
|
haemoglobin |
lymphocytes |
liver |
Ethane |
2730±100 |
5.8±2.2 |
7.4±1.0 |
Propene |
740 ±50 |
1.8 ±0.9 |
2.8 ±0.9 |
1-butene |
20±1 |
0.8±0.4 |
2.1±0.5 |
1-pentene |
51±3 |
0.5±0.2 |
1.8±0.6 |
1-hexene |
39±1 |
0.3±0.3 |
1.4±0.2 |
1-heptene |
11±1 |
0.4±0.1 |
1.3±0.4 |
1-octene |
1.7±0.5 |
0.2±0.2 |
1.3±0.6 |
C2 background |
25±3 |
1.6±0.2 |
3.0±0.7 |
C3 background |
1.3±0.3 |
nd |
nd |
Background values have been subtracted
N = 3-8 for haemoglobin and 4 for DNA adduct analysis
ND = not detectableApplicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): low bioaccumulation potential based on study results
Rats exposed to 300ppm of 1-alkenes of from C2-C8 (including 1-butene) for 12h for 3 days had increased concentrations of the alkenes in blood and tissues proportional to increasing numbers of carbon atoms. In contrast, levels of haemoglobin and DNA adducts decreased with increasing numbers of carbon atoms. The 1-alkenes were widely distributed within the body with the lowest concentrations in blood and the highest in fat. Concentrations of 1-butene (micromol/kg tissue) were: blood 1.9, liver 0.8, lung 4.9, brain 3.0, kidneys 5.7, fat 70. DNA adducts (N-7 alkyl guanine) (adducts/107 nucleotides) were: lymphocytes 0.8, liver 2.1 after exposure to 1-butene. - Executive summary:
The absorption, distribution, elimination, haemoglobin adduct formation and DNA adduct formation of individual C2-C8 1-alkenes was studied in the rat after exposure to 300 ppm (688mg/m3), 12 h a day for 3 consecutive days. The concentrations of the alkenes were measured in blood, lung, brain, liver, kidney and peri-renal fat immediately after each exposure and 12 h after the third exposure. DNA adducts were determined by 32P-postlabeling in liver. Haemoglobin adducts were determined in erythrocytes by GC/MS and GC/MS/MS. Concentrations of 1-alkenes in blood and organs reached a steady-state level after the first 12 h exposure, and the concentrations 12 h after the last exposure were generally low, except in fat. Concentrations of 1-alkenes in blood and the different tissues increased with increasing number of carbon atoms. However, DNA adducts and haemoglobin adducts decreased with increasing number of carbon atoms with the most pronounced decrease being from C2 to C3. The decrease in haemoglobin adducts was more pronounced than DNA adducts. All 1-alkenes caused formation of detectable levels of haemoglobin and DNA adducts, although the levels of haemoglobin adducts after C4-C8 exposure were low. These results also indicate that extrapolation within the homologous series is possible.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.